Pleiotropic role for<i>MYCN</i>in medulloblastoma
Fredrik J. Swartling(University of California, San Francisco), Louis Chesler(Institute of Cancer Research)
Cited by 174
Related Papers
Inhibition of Phosphatidylinositol 3-Kinase Destabilizes Mycn Protein and Blocks Malignant Progression in Neuroblastoma
|Cancer Research|2006|198
Inhibition of mTOR-kinase destabilizes MYCN and is a potential therapy for MYCN-dependent tumors
|Oncotarget|2016|57
BET and Aurora Kinase A inhibitors synergize against MYCN-positive human glioblastoma cells
|Cell Death and Disease|2019|36
Molecular and In Vivo Characterization of Cancer-Propagating Cells Derived from MYCN-Dependent Medulloblastoma
|PLoS ONE|2015|27
ARF suppression by MYC but not MYCN confers increased malignancy of aggressive pediatric brain tumors
|Nature Communications|2023|21